|
ATL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.167000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.788400E-01 |
| Normal-vs-Stage2 |
6.200100E-04 |
| Normal-vs-Stage3 |
1.360190E-01 |
| Normal-vs-Stage4 |
6.075900E-02 |
| Stage1-vs-Stage2 |
1.662290E-03 |
| Stage1-vs-Stage3 |
3.790200E-01 |
| Stage1-vs-Stage4 |
1.449390E-01 |
| Stage2-vs-Stage3 |
1.467730E-02 |
| Stage2-vs-Stage4 |
4.418100E-02 |
| Stage3-vs-Stage4 |
6.038200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.137400E-01 |
| Normal-vs-AfricanAmerican |
6.566400E-01 |
| Normal-vs-Asian |
3.040000E-01 |
| Caucasian-vs-AfricanAmerican |
6.900400E-01 |
| Caucasian-vs-Asian |
9.882400E-01 |
| AfricanAmerican-vs-Asian |
6.901600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.216800E-01 |
| Normal-vs-Female |
1.068020E-01 |
| Male-vs-Female |
7.190000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.556000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.639600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.108210E-02 |
| Normal-vs-Age(81-100Yrs) |
2.479600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.203500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.363900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.546400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.907000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.684400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.182800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.339600E-01 |
| Classical-VS-Follicular |
2.99860000163577E-08 |
| Classical-VS-Other |
3.733800E-01 |
| Classical-VS-Normal |
7.116600E-01 |
| Tall-VS-Follicular |
6.620100E-04 |
| Tall-VS-Other |
2.937200E-01 |
| Tall-VS-Normal |
9.382600E-01 |
| Follicular-VS-Other |
3.521600E-01 |
| Follicular-VS-Normal |
6.39000000000056E-05 |
| Other-VS-Normal |
3.173200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.260500E-03 |
| Normal-vs-N1 |
5.006600E-01 |
| N0-vs-N1 |
3.550200E-02 |
|
|
